SCHEMBL1012933

SCHEMBL1012933

COC(=O)c1cc(Cl)ccc1NC(=O)CSCC(=O)Nc1cccc(-c2ccoc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 5/20 0.61
CNR1 P21554 1/20 0.53
ALDH1A1 P00352 3/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
LMNA P02545 3/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 2/20 0.44
GAA P10253 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALOX15 P16050 1/20 0.43
HTT P42858 1/20 0.43
KLK7 P49862 1/20 0.42
RAB9A P51151 1/20 0.41
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015662 0.91 SERPINE1 (0.64) SERPINE1CNR1ALDH1A1MEN1KMT2A
SCHEMBL1014817 0.89 SERPINE1 (0.76) SERPINE1CNR1ALDH1A1MEN1KMT2A
SCHEMBL1015090 0.87 SERPINE1 (0.79) SERPINE1CNR1ALDH1A1MEN1KMT2A
SCHEMBL1015300 0.86 ALDH1A1 (0.59) SERPINE1CNR1ALDH1A1MEN1KMT2A
SCHEMBL1016855 0.86 SERPINE1 (0.50) SERPINE1ALDH1A1MEN1KMT2ALMNA
SCHEMBL1016354 0.86 CNR1 (0.50) SERPINE1CNR1ALDH1A1MEN1KMT2A
SCHEMBL418556 0.83 SERPINE1 (0.61) SERPINE1CNR1ALDH1A1MEN1KMT2A
SCHEMBL1012706 0.82 SERPINE1 (0.80) SERPINE1CNR1ALDH1A1MEN1KMT2A
SCHEMBL419000 0.82 SERPINE1 (0.60) SERPINE1CNR1ALDH1A1HPGDGAA
SCHEMBL419148 0.82 SERPINE1 (0.82) SERPINE1ALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885CNR1 3950/4885ALDH1A1 888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.